The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
Open accessAbstract
Proguanil and pyrimethamine are antifolate drugs with distinct chemical structures that are used commonly in the prophylaxis and treatment of Plasmodium falciparum malaria. Clinical reports and field studies have suggested that some parasites refractory to proguanil can be treated with pyrimethamine, and vice versa. Analysis of the P. falciparum dihydrofolate reductase (DHFR) from different parasites reveals the structural basis for differential susceptibility to these antifolate drugs. Parasites harboring a pair of point mutations from Ala-16 to Val-16 and from Ser-108 to Thr-108 are resistant to cycloguanil (the active metabolite of proguanil) but not to pyrimethamine. A single Asn-108 mutation, on the other hand, confers resistance to pyrimethamine with only a moderate decrease in susceptibility to cycloguanil. Significant cross-resistance to both drugs occurs in parasites having mutations that include Ser-108----Asn-108 and Ile-164----Leu-164. These results reflect the distinct structures of pyrimethamine and cycloguanil and suggest fine differences in binding within the active site cavity of DHFR. Alternative inhibitors, used alone or in combination, may be effective against some strains of cycloguanil- or pyrimethamine-resistant malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Malaria Parasites in Continuous Culture
Trager, W., & Jensen, J. B. (1976) · Science · doi:10.1126/science.781840 · Cited by 7,844
Innis, M. A., Myambo, K. B., Gelfand, D. H., & Brow, M. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9436 · Cited by 775
Genetic Analysis of the Human Malaria Parasite Plasmodium falciparum
Walliker, D., Quakyi, I. A., Wellems, T. E., McCutchan, T. F., Szarfman, A., London, W. T., Corcoran, L. M., Burkot, T. R., & Carter, R. (1987) · Science · doi:10.1126/science.3299700 · Cited by 742
Self-citationPeterson, D. S., Walliker, D., & Wellems, T. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9114 · Cited by 653
Self-citationCowman, A. F., Morry, M. J., Biggs, B. A., Cross, G. A., & Foote, S. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9109 · Cited by 526
Isolation and expression of an altered mouse dihydrofolate reductase cDNA.
Simonsen, C. C., & Levinson, A. D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2495 · Cited by 417
Dihydrofolate Reductase: X-ray Structure of the Binary Complex with Methotrexate
Matthews, D. A., Alden, R. A., Bolin, J. T., Freer, S. T., Hamlin, R., Xuong, N., Kraut, J., Poe, M., Williams, M., & Hoogsteen, K. (1977) · Science · doi:10.1126/science.17920 · Cited by 322
Foote, S. J., Galatis, D., & Cowman, A. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3014 · Cited by 301
Bzik, D. J., Li, W. B., Horii, T., & Inselburg, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8360 · Cited by 258
Matthews, D. A., Alden, R. A., Bolin, J. T., Filman, D. J., Freer, S. T., Hamlin, R., Hol, W. G., Kisliuk, R. L., Pastore, E. J., Plante, L. T., et al. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38012-2 · Cited by 226
Cited by
Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. D., Malkin, E. M., Cortese, J. F., Martino, L. M., Mukadam, R. A. G., Rogerson, S. J., Lescano, A. G., Molyneux, M. E., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338566 · Cited by 523
Mechanisms of Resistance of Malaria Parasites to Antifolates
Gregson, A., & Plowe, C. V. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.4 · Cited by 499
Triglia, T., Menting, J. G. T., Wilson, C., & Cowman, A. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13944 · Cited by 422
Plowe, C. V., Cortese, J. F., Djimde, A., Nwanyanwu, O. C., Watkins, W. M., Winstanley, P. A., Estrada‐Franco, J. G., Mollinedo, R. E., Avila, J. C., Cespedes, J. L., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514159 · Cited by 414
Wu, Y., Kirkman, L. A., & Wellems, T. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1130 · Cited by 378
Self-citationBrooks, D. R., Wang, P., Read, M., Watkins, W. M., Sims, P. F. G., & Hyde, J. E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00397.x · Cited by 369
Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?
Sibley, C. H., Hyde, J. E., Sims, P. F. G., Plowe, C. V., Kublin, J. G., Mberu, E. K., Cowman, A. F., Winstanley, P. A., Watkins, W. M., & Nzila, A. M. (2001) · Trends in Parasitology · doi:10.1016/s1471-4922(01)02085-2 · Cited by 369
Su, X.-Z., Kirkman, L. A., Fujioka, H., & Wellems, T. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80447-x · Cited by 347
Self-citationAntifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase
Sirawaraporn, W., Sathitkul, T., Sirawaraporn, R., Yuthavong, Y., & Santi, D. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1124 · Cited by 341
Biochemical, genetic and applied aspects of drug resistance in Eimeria parasites of the fowl
Chapman, H. D. (1997) · Avian Pathology · doi:10.1080/03079459708419208 · Cited by 322
History, Dynamics, and Public Health Importance of Malaria Parasite Resistance
Talisuna, A. O., Bloland, P., & D’Alessandro, U. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.235-254.2004 · Cited by 322
Deitsch, K. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.3.850 · Cited by 318
White, N. J., & Olliaro, P. L. (1996) · Parasitology Today · doi:10.1016/0169-4758(96)10055-7 · Cited by 307
Foote, S. J., Galatis, D., & Cowman, A. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3014 · Cited by 301
A Mechanism for the Synergistic Antimalarial Action of Atovaquone and Proguanil
Srivastava, I. K., & Vaidya, A. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1334 · Cited by 299
Yuthavong, Y., Tarnchompoo, B., Vilaivan, T., Chitnumsub, P., Kamchonwongpaisan, S., Charman, S. A., McLennan, D. N., White, K. L., Vivas, L., Bongard, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204556109 · Cited by 277
Current status of malaria and potential for control
Phillips, R. S. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.208-226.2001 · Cited by 266
Wang, P., Lee, C.-S., Bayoumi, R., Djimde, A., Doumbo, O., Swedberg, G., Dao, L. D., Mshinda, H., Tanner, M., Watkins, W. M., et al. (1997) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(97)00114-x · Cited by 261
Preventing antimalarial drug resistance through combinations
White, N. J. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80208-2 · Cited by 259
Nzila, A. M., Mberu, E. K., Sulo, J., Dayo, H., Winstanley, P. A., Sibley, C. H., & Watkins, W. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.991-996.2000 · Cited by 232
Ma, L., Borio, L., Masur, H., & Kovacs, J. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/315148 · Cited by 169
“In Plasmodium species, it has been well established that DHFR point mutations are responsible for differential resistance to DHFR inhibitors [4–7], whereas DHPS point mutations are associated with sulfa resistance [8–10].”
BackgroundSridaran, S., McClintock, S. K., Syphard, L. M., Herman, K. M., Barnwell, J. W., & Udhayakumar, V. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-247 · Cited by 124
Recent advances in antimalarial drug development
Vangapandu, S., Jain, M., Kaur, K., Patil, P., Patel, S. R., & Jain, R. (2007) · Medicinal Research Reviews · doi:10.1002/med.20062 · Cited by 108
Metadata
- Authors
- Peterson, D. S., Milhous, W. K., & Wellems, T. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-04
- Volume
- 87
- Issue
- 8
- Pages
- 3018-3022
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1976176203
- Cited by
- 419
- References
- 18
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.